Home
About
Overview
Sharing Data
ORCID
Help
History (48)
Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series.
Broad Host Range of SARS-CoV-2 Predicted by Comparative and Structural Analysis of ACE2 in Vertebrates.
Genetic alterations in renal cell carcinoma with rhabdoid differentiation.
Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations.
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
See All 48 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
Maron MS, Rowin EJ, Maron BJ. Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten? Asian Cardiovasc Thorac Ann. 2022 Jan; 30(1):11-18.
View in:
PubMed
subject areas
Benzylamines
Cardiomyopathy, Hypertrophic
Humans
Treatment Outcome
Uracil
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA